View Press Releases
Rho to Discuss Project Management Best Practices at DIA 2018
CHAPEL HILL, NC, UNITED STATES - Jun 21, 2018 - WHAT: Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the Drug Information Association (DIA) Annual Meeting, being held June 24-28 in Boston.
Many Rho experts will be in attendance, including Shann Williams; senior director, operations; who will share her expertise as both a chairperson and a speaker for the project management and strategic planning track.
- Shann Williams will serve as the chairperson for the project management and strategic planning track session, FUNdamentals of Project Management. She will also present Can a Trial be Agile? Exploring Methodology for Clinical Project Management during this session, where she will share her insights on best practices and navigating project management pitfalls.
Event attendees are invited to stop by Rhos booth #2003 to meet the experts and learn more about how the company can help ensure an efficient and a successful drug development process.
WHO: Rho experts at the 2018 DIA Annual Meeting:
- Shann Williams - senior director, operations
WHEN: June 24-28, 2018
WHERE: Boston Convention & Exhibition Center
415 Summer Street
Boston, MA 02210
DETAILS: For media inquiries, please contact Bernadette Miller at Largemouth Communications, (703) 297-5992, email@example.com.
ABOUT: Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 34 years, Rho has been a trusted partner to some of the industrys leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.